Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1996
05/21/1996US5519053 5-Iodo-6-amino-1,2-Benzopyrones and their metabolites useful as cytostatic agents
05/21/1996US5519036 Cyclic derivatives pharmaceutical compositions containing these compounds and processes for preparing them
05/21/1996US5519032 Antidepressants, anxiolytics, antiemetics, antipsychotic
05/21/1996US5519022 α, α dialkylbenzyl derivatives
05/21/1996US5519020 Polymer adducts which release nitric oxide
05/21/1996US5519005 Guanidine terminated peptides for treatment of thrombosis, antitumor agents, autoimmune diseases and immunology
05/21/1996US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability
05/21/1996US5518735 Anticoagulants administered by mouth
05/21/1996CA2017573C 4-(hydroxydiphenylmethyl)-1-piperidylphenylalkane derivatives as antihistamines and a method of treatment of an allergic response
05/21/1996CA1338344C Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
05/19/1996CA2163158A1 Methods for inhibiting bone loss
05/18/1996CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
05/17/1996WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR
05/17/1996WO1996014401A1 Transgenic organisms and their uses
05/17/1996WO1996014394A1 Human dna ligase iii
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014331A1 Modified neuropeptide y receptors
05/17/1996WO1996014330A1 Amino acid nucleic acids
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014325A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996WO1996014324A1 Smooth muscle cell proliferation inhibitors
05/17/1996WO1996014323A1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996WO1996014318A1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
05/17/1996WO1996014317A1 Novel piperidine derivatives with paf antagonist activity
05/17/1996WO1996014314A2 Thiepane compounds inhibiting and detecting hiv protease
05/17/1996WO1996014307A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
05/17/1996WO1996014306A1 Forms a and b of n-[[[2-[[[2-[(diaminomethylen)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylen]-4-bromobenzenosulphonamide
05/17/1996WO1996014302A1 Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
05/17/1996WO1996014300A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities
05/17/1996WO1996014111A1 Golf club receptacle
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996014067A1 Cysteine protease and serine protease inhibitors
05/17/1996WO1996004266A3 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
05/17/1996CA2204530A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation
05/17/1996CA2203935A1 Transgenic organisms and their uses
05/17/1996CA2203570A1 Thiepane compounds inhibiting and detecting hiv protease
05/17/1996CA2202274A1 Amino acid nucleic acids
05/17/1996CA2197306A1 Cysteine protease and serine protease inhibitors
05/15/1996EP0711829A2 Recombinant alphavirus vectors
05/15/1996EP0711757A1 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
05/15/1996EP0711755A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
05/15/1996EP0711555A2 Enzyme inactivators
05/15/1996EP0711346A1 Agonists and antagonists of human interleukin-10
05/15/1996EP0711308A1 Cell adhesion protein complexes with copper
05/15/1996EP0711299A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS
05/15/1996EP0711296A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
05/15/1996EP0711293A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
05/15/1996EP0711291A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists
05/15/1996EP0711290A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives
05/15/1996EP0711289A1 Piperazine compounds used in therapy
05/15/1996EP0711288A1 Piperazine derivatives as alpha 1a-adrenergic receptor antagonists
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711281A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists
05/15/1996EP0711280A1 Perhydroisoindole derivatives as p substance antagonists
05/15/1996EP0711279A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists
05/15/1996EP0711278A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents
05/15/1996EP0711174A1 Programmed cell death genes and proteins
05/15/1996EP0711168A1 Methods of treating apoptosis and associated conditions
05/15/1996EP0711167A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/15/1996EP0711163A1 Use of benzydamine in the treatment of pathological conditions caused by tnf
05/15/1996EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
05/15/1996EP0711157A1 Endothelin receptor antagonists
05/15/1996EP0711141A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea
05/15/1996EP0465565B1 Treatment of aids dementia, myelopathy and blindness
05/15/1996EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy
05/15/1996EP0456835B1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof
05/15/1996CN1122591A Large potassium bicarbonate crystals and process for the preparation thereof
05/15/1996CN1122338A Physical form of dihydro-2,3-benzodiazepine derivative
05/15/1996CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid
05/14/1996US5516940 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
05/14/1996US5516936 Inhibitors of kynureninase
05/14/1996US5516807 Administering a polyamine to a patient to treat or prevent restenosis
05/14/1996US5516806 Ornithine decarboxylase inhibiting cyclic aminooxy compounds
05/14/1996US5516805 Antiischemic agents, anticarcinogenic agents and antiarrhythmia agents for cardiovascular disorders
05/14/1996US5516785 Anabaseine, stimulating brain cholinergic transmission
05/14/1996US5516783 Platelet activating factor
05/14/1996US5516778 Method for improving tissue antioxidant status
05/14/1996US5516775 Further use of pyrimidine derivatives
05/14/1996US5516774 Treating diseases characterized by excess renal reabsorption of water
05/14/1996US5516771 Use of indolocarbazole derivatives to treat a pathological condition of the prostate
05/14/1996US5516673 Preactivation of cellulose, polyvinyl alcohol, or the like with pyridine, pyrrole, pyridazine or their derivatives; further reaction with proteins; wound healing agents
05/14/1996US5516533 Fluidized intestinal submucosa and its use as an injectable tissue graft
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013598A2 Hybrid adenovirus-aav virus and method of use thereof
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013500A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013492A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
05/09/1996WO1996013491A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013485A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
05/09/1996WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis
05/09/1996WO1996013483A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
05/09/1996WO1996013290A1 Device for aerosolized delivery of peptide drugs
05/09/1996WO1996013286A2 Modulation of cell proliferation and wound healing
05/09/1996WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
05/09/1996WO1996013269A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996WO1996013262A1 Muscarine antagonists
1 ... 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 ... 1564